Comment on CMS-2026-1255-0001

Summary: The American College of Medical Genetics and Genomics (ACMG) supports the proposed rule to expand electronic prior authorization (ePA) requirements to all drugs to improve timeliness and transparency in patient care. They argue that streamlining these processes and standardizing test requisition forms will reduce administrative burdens on healthcare professionals and minimize delays in diagnostic testing for genetic disorders.